NASDAQ:AVGRAvinger Stock Price, Forecast & News

Avinger's stock was trading at $0.43 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AVGR shares have decreased by 22.8% and is now trading at $0.3320. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Avinger.

Avinger is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Avinger.

Avinger Inc (NASDAQ:AVGR) released its quarterly earnings data on Wednesday, May, 13th. The medical device company reported ($0.47) EPS for the quarter, missing the consensus estimate of ($0.41) by $0.06. The medical device company earned $2.26 million during the quarter. Avinger had a negative return on equity of 270.15% and a negative net margin of 211.96%. View Avinger's earnings history.

Shares of Avinger reverse split before market open on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.

Avinger updated its first quarter 2020 After-Hours earnings guidance on Wednesday, April, 15th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.25-2.25 million, compared to the consensus revenue estimate of $2.56 million.

2 brokers have issued 12-month target prices for Avinger's stock. Their forecasts range from $1.40 to $1.40. On average, they expect Avinger's share price to reach $1.40 in the next twelve months. This suggests a possible upside of 321.7% from the stock's current price. View analysts' price targets for Avinger.

Press coverage about AVGR stock has trended negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Avinger earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave media stories about the medical device company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Avinger.

Some companies that are related to Avinger include Motus GI (MOTS), STRATA Skin Sciences (SSKN), Apollo Endosurgery (APEN), Neuronetics (STIM), Atossa Genetics (ATOS), Arch Therapeutics (ARTH), Delcath Systems (DCTH), Neovasc (NVCN), Interpace Diagnostics Group (IDXG), DarioHealth (DRIO), Biostage (BSTG), Sintx Technologies (SINT), Endologix (ELGX), Dynatronics (DYNT) and Lianluo Smart (LLIT). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Avinger investors own include AcelRx Pharmaceuticals (ACRX), Actinium Pharmaceuticals (ATNM), Onconova Therapeutics (ONTX), Palatin Technologies (PTN), Biocept (BIOC), Micron Technology (MU), Rigel Pharmaceuticals (RIGL), Alibaba Group (BABA), Canopy Growth (CGC) and Genocea Biosciences (GNCA).

(AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company acted as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AVGR stock can currently be purchased for approximately $0.33.

Avinger has a market capitalization of $10.40 million and generates $9.13 million in revenue each year. The medical device company earns $-19,450,000.00 in net income (profit) each year or ($3.18) on an earnings per share basis.

The official website for Avinger is www.avinger.com.

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected]